DANIEL CROWE: Open Payments
NPI 1245409622 · FAITH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,825 in 154 payments from 30 companies in 2025. Trend: 2023 $2,887 · 2024 $2,866 · 2025 $2,825
Food & beverage: $2,825
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 19 | $358 |
| Amgen Inc. | 19 | $315 |
| ABBVIE INC. | 18 | $285 |
| AstraZeneca Pharmaceuticals LP | 11 | $283 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $230 |
| Novo Nordisk Inc | 13 | $210 |
| Bayer Healthcare Pharmaceuticals Inc. | 11 | $182 |
| Axsome Therapeutics, Inc. | 4 | $84 |
| Viatris Specialty LLC | 3 | $78 |
| Phathom Pharmaceuticals, Inc. | 4 | $72 |
Products named: ELIQUIS, CAPLYTA, FARXIGA, Kerendia, EVENITY, OTEZLA, Wegovy, VRAYLAR.
Industry payments across NC — which companies pay providers there.
